Lyme Disease Diagnostic Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Global Lyme Disease Diagnostic Market is segmented by Diagnostic Technology (Serological Test (ELISA, Western Blot), Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining, Nucleic acid Test), by End-Users (Hospital, Clinical Laboratories, Other End-Users) and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report offers the value (in USD million) for the above segments.

Lyme Disease Diagnostic Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Lyme Disease Diagnostic Industry Overview

The Lyme disease diagnostic market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are in the market are Abbott, Bio-Rad Laboratories, Inc., Covance Inc., F. Hoffmann-La Roche AG, T2 Biosystems, Inc, and Oxford Immunotec USA, Inc..

Lyme Disease Diagnostic Market Leaders

  1. T2 Biosystems, Inc

  2. Bio-Rad Laboratories

  3. Oxford Immunotec USA, Inc

  4. ROCHE DIAGNOSTICS INTERNATIONAL LTD

  5. Abbott

  6. *Disclaimer: Major Players sorted in no particular order
Lyme Disease Diagnostic Market.png

Lyme Disease Diagnostic Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?